CDK5RAP2 and breast cancer: We have therefore examined loss-of-function phenotypes of CEP215 in two cell lines with centrosome amplification: the mouse neuroblastoma line N1E-115 and the human breast cancer cell line BT459, with respective incidences of >99% and ∼25% supernumerary centrosomes.